HIV and Women's Health in the United States

HIV affects women across the US, and the practical answers are clear: it's a manageable, lifelong condition. Early symptoms mimic the flu or cause none at all, so only a test confirms it. Treatment leads to an undetectable viral load that protects partners, and PrEP prevents new infections.

What HIV is

HIV is a virus that attacks the immune system, specifically the CD4 cells that coordinate your body's defenses CDC, About HIV. Left untreated, it moves through three stages. The acute stage comes first, when the virus replicates fast and the viral load is very high, which is when a person is most contagious. Next is chronic infection, or clinical latency, where the virus stays active but at lower levels and can quietly persist for a decade or more with no symptoms. The final stage is AIDS, the most advanced point, defined by a CD4 count under 200 cells/mm³ or by an opportunistic infection that takes hold because the immune system has been worn down.

There's no cure. Once you have HIV, you have it for life StatPearls. But treatment changes the whole trajectory. It controls the virus so well that a woman who starts care before her immune system is damaged can expect a lifespan approaching that of the general population Lancet HIV. Control is not the same as cure, and that distinction shapes the decisions below.

Symptoms — and the silent reality

Within two to four weeks of infection, most people develop a flu-like illness called acute retroviral syndrome hiv.gov. Around 90% of newly infected people get some version of it: fever, chills, rash, night sweats, muscle aches, sore throat, fatigue, swollen lymph nodes, and mouth ulcers. Those symptoms hit exactly when the viral load peaks above a million copies/mL, the same moment when onward transmission risk is highest.

These symptoms look exactly like a bad cold or the flu, so they're easy to brush off, and some women have no symptoms at all. Symptoms can neither confirm nor rule out HIV; they're a prompt to test, never a diagnosis. After the acute phase passes, years can go by feeling completely fine while the virus stays active. The only reliable way to know your status is a test.

How HIV spreads

Only certain body fluids carry enough virus to transmit HIV: blood, semen, vaginal fluid, rectal fluid, and breast milk CDC, How HIV Spreads. The main routes are anal or vaginal sex, sharing needles or other injection equipment, and passing it from mother to child during pregnancy, childbirth, or breastfeeding.

What does not spread HIV matters too. The virus doesn't survive long outside the body, so you can't get it from saliva, kissing, hugging, sharing food or utensils, toilet seats, surfaces, swimming pools, mosquitoes, or donating blood. Knowing the real routes cuts through a lot of needless fear and stigma.

How HIV is tested

Testing is quick and often free. A finger-stick or oral-swab rapid test gives results in minutes, a lab blood draw is more sensitive, and at-home kits let you test privately. Health departments offer it at no cost, and you can also compare options to plan your screening — see how to get tested or compare testing providers.

There's a window period, the gap after exposure before a test can reliably detect the virus CDC, HIV Testing. A nucleic-acid test (NAT) can detect HIV roughly 10 to 33 days after exposure; a fourth-generation antigen/antibody lab test, about 18 to 45 days; and antibody or rapid tests, about 23 to 90 days. A negative result only counts as conclusive once you're past the window with no exposure during it. For a deeper walk-through of timing and how to interpret an early negative, see our guide on hiv testing and on when to test after exposure.

The USPSTF gives HIV screening a Grade A recommendation: everyone ages 15 to 65 should be tested at least once, and those with ongoing risk should test more often, at least annually per the CDC USPSTF Grade A. Don't assume age rules you out. New diagnoses happen across the lifespan, and many older adults discover hiv/aids isn’t a young person’s disease.

Treatment

Everyone diagnosed with HIV should start antiretroviral therapy (ART) as soon as possible CDC, HIV Treatment. ART is a combination of medicines, with drug classes including integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors, and for many people it's now a single daily pill. The goal is an undetectable viral load, meaning so little virus remains in the blood that standard tests can't measure it. Most people reach that point within about six months of starting treatment.

Treatment is lifelong. Undetectable is control, not cure: latent HIV reservoirs persist in cells and tissues, and the virus rebounds if treatment stops HHS clinicalinfo. A handful of people have reached long-term remission after stem-cell transplants done for cancer — the Berlin patient, the London patient, and a New York woman documented as the third case and the first woman NIH, 2022 — but those used rare HIV-resistant donor cells, carry serious risk, and aren't a scalable cure. A true cure remains a research goal, not an option you can choose today NIAID research. For dosing details and how to start, see our overview of hiv treatment.

Complications if untreated

Without treatment, HIV slowly destroys the immune system until it reaches AIDS, the stage defined by a CD4 count under 200 or an opportunistic infection. Opportunistic infections are illnesses a healthy immune system would normally fight off easily, such as certain pneumonias, fungal infections, and cancers; they become dangerous because the body's defenses have collapsed. The progression usually takes years. Early detection and prompt ART prevent the immune damage from ever getting that far.

For women who are pregnant, untreated HIV also risks passing the virus to the baby. With ART during pregnancy and labor plus newborn prophylaxis, perinatal transmission can be reduced to less than 1%. That depends on a woman knowing her status and starting care.

Prevention

The CDC's core prevention toolkit is condoms, PrEP, PEP, treatment-as-prevention (U=U), and regular testing CDC, PrEP. Each plays a different role, and they stack.

PrEP — pre-exposure prophylaxis — is medicine for people who don't have HIV but may be exposed through sex or injection drug use. Taken as prescribed, it reduces HIV risk from sex by about 99%. Options include daily Truvada and Descovy pills and the long-acting injectable cabotegravir (Apretude), given as two starter doses a month apart and then every two months. For women, one important detail: Descovy is not approved for people at risk through receptive vaginal sex because its trials didn't include cisgender women, so Truvada and the cabotegravir shot are the approved choices. Starting PrEP requires a confirmed HIV-negative test first, then follow-up testing every three months for pills or every two months for the injection, because starting with an undiagnosed infection risks drug resistance.

Newer long-acting PrEP is a major step forward: in the PURPOSE 1 trial, twice-yearly injectable lenacapavir produced zero infections among women WHO. Below is how the main methods compare.

PEP — post-exposure prophylaxis — is the emergency option after a possible exposure. It must start within 72 hours and is taken daily for a 28-day course CDC, PEP. If you think you were just exposed, that's an urgent-care or ER conversation today, not a wait-and-test one. PEP is for emergencies and isn't a substitute for PrEP or condoms.

Treatment itself is prevention. A woman with HIV who takes her medicine and stays undetectable will not transmit the virus to sex partners — Undetectable equals Untransmittable, or U=U CDC, U=U. Across the PARTNER, Opposites Attract, and PARTNER2 studies, mixed-status couples logged more than 125,000 condomless sex acts with zero linked transmissions from a partner whose viral load was undetectable Lancet PARTNER.

When to see a clinician

Get tested at least once as routine care, and sooner if any of these apply. Time-sensitive situations come first.

• You may have been exposed in the last 72 hours — go to urgent care or an ER the same day to ask about PEP; this can't wait.
• You have flu-like symptoms after a possible risk: fever, rash, sore throat, or swollen glands two to four weeks out warrant an urgent test rather than waiting to see.
• You have new or multiple sex partners, a partner whose status you don't know, or you inject drugs — talk to a clinician about PrEP and routine testing.
• You're pregnant or planning a pregnancy — early testing and ART make passing HIV to the baby almost entirely preventable.
• You've never been tested — everyone 15 to 65 should be screened at least once.